BIOAVENGE
BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of genes and gene expression, and genetic sequences of biological significance into a gene discovery, functional analysis, and identification of bio hazardous agents. It also utilizes its technology for target validation, screening bio hazardous contamination, diagnostic applications, and prophylactic and therapeutic vaccine development. The company was founded in 2000 and is based in Gaithersburg, Maryland. As of February 12, 2008, BioAvenge operates as a subsidiary of GateKeeper USA, Inc. (OTCPK:GTKP).
BIOAVENGE
Industry:
Biotechnology Genetics
Founded:
2000-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Status:
Active
More informations about "BioAvenge"
BioAvenge - Crunchbase Company Profile & Funding
BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of genes and gene expression, and genetic sequences of biological significance into a gene discovery, functional analysis, and โฆSee details»
BioAvenge - Crunchbase
BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study ofSee details»
BioAvenge - Company Profile and News - Bloomberg Markets
Company profile page for BioAvenge including stock price, company news, executives, board members, and contact informationSee details»
GateKeeper USA acquires BioAvenge - 2008-02-06 - Crunchbase
BioAvenge BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of. Acquiring Organization: GateKeeper โฆSee details»
Avenge Bio Announces FDA Clearance of the AVB-001 โฆ
Aug 3, 2022 Avenge Bio expects to initiate a Phase 1 clinical trial in the second half of 2022 for patients with metastatic peritoneal cancers with an initial focus on platinum-resistant ovarian cancerSee details»
Tech Transfer From Client Avenge Bio Results in First โฆ
Newark, New Jersey โ January 17, 2023 โ BioCentriq, Inc.โa New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)โannounced today that they have successfully โฆSee details»
BioAvenge Company Profile, Financial and Strategic SWOT โฆ
BioAvenge possesses genomic and proteomic technology platforms. The company unites its technology platforms for the analytical study of genes and gene expression, and genetic โฆSee details»
BioAvenge+organization - NL Classifieds
Find Bioavenge+organization in Lawn & Garden | Find new & used lawn & garden items for sale. Shop the latest items in lawn and garden including BBQs & grills, generators, snow blowers, โฆSee details»
BioAvenge - biobank.co.kr
BioAvenge subsidiary of GateKeeper USA Inc. 9620 Medical Center Drive. Suite 100. Rockville. MD 20850 USA +1-631-499-3684 +1-631-499-3682: www.gatekeeperusainc.com: โฆSee details»
Avenge Bio - Craft
Avenge Bio is a company developing cell-generated immunotherapies to treat solid tumors. It offers a drug delivery platform that allows users to order cytokines and other โฆSee details»
BIOAVENGE - Dun & Bradstreet
Bioavenge was founded in 2008, and is located at 9290 Gaither Rd in Gaithersburg. It employs 11 employees and is generating approximately $710,000.00 in annual revenue. Additional โฆSee details»
BioAvenge organization à vendre Montréal | LesPAC
BioAvenge organization à vendre à Montréal. Trouvez tout ce dont vous avez de besoin directement sur LesPAC! Que vous souhaitiez vendre ou acheter quelque chose par rapport โฆSee details»
Avenge Bio Announces Closing of $45 Million Series A Financing
NATICK, Mass., Jan. 5, 2022 /PRNewswire/ -- Avenge Bio, Inc., a biotechnology company developing the LOCOcyteโข immunotherapy platform for the precision administration of potent โฆSee details»
Avenge Bio Receives FDA Orphan Drug Designation for AVB-001 โฆ
Jun 15, 2023 NATICK, Mass. and QUINCY, Mass., June 15, 2023 /PRNewswire/ -- Avenge Bio, Inc. ("Avenge"), a clinical stage, oncology-focused biotechnology company developing the โฆSee details»
Bioavenge+organization | New & Used Personal Care Items for โฆ
Find Bioavenge+organization in Personal Care | Find new & used personal care items for sale. View all personal care items for sale near you including hair dryers, curling irons & โฆSee details»
BioAvenge+organization - NL Classifieds
Find Bioavenge+organization in BBQs, Grills & Outdoor Cooking | Find new & used BBQs, grills & other outdoor cooking items for sale. Shop the largest local selection of new and used BBQs, โฆSee details»
AvengeBio - Crunchbase Company Profile & Funding
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors. It is a developer of a drug delivery platform intended to treat cancer.See details»
15 Biggest NGOs in Canada - Human Rights Careers
Globally, the NGO reached 13 million people in 2022. That same year, Canadaโs branch reached over 17,000 people through its programs that focus on emergency relief, transformational โฆSee details»
Ravel Biotechnology - Crunchbase
Organization. Ravel Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. ... BioAvenge โฆSee details»
AvengeBio - Funding, Financials, Valuation & Investors - Crunchbase
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.See details»